News & Analysis as of

Pharmaceutical Distribution Infectious Diseases

Robinson+Cole Health Law Diagnosis

HHS Again Requires FDA Premarket Review for COVID-19 Tests

On Monday, November 15, 2021, the Food and Drug Administration (FDA) announced that the U.S. Department of Health and Human Services (HHS) repealed a policy established by the Trump administration that directed the FDA not to...more

Littler

Ontario, Canada Exploring Possibility of Allowing Employer-Operated Onsite Vaccination Clinics in “Hot Spot” Communities

Littler on

On April 13, 2021, Ontario announced that in Phase 2 of its COVID-19 vaccine distribution plan it will provide vaccines to those 18 and over via mass immunization clinics, mobile teams, and pop-up clinics in highly impacted...more

Mintz - Health Care Viewpoints

Bioethics in a Pandemic: Operation Warp Speed

References to Operation Warp Speed (OWS) have been present throughout our coverage of the ethical questions related to the development and distribution of a COVID-19 vaccine. In fact, OWS is part of a broader public-private...more

Manatt, Phelps & Phillips, LLP

COVID-19 Vaccine Distribution: Key Challenges and Outstanding Questions

On September 16, 2020, the Trump Administration issued, for the first time, a planning framework for allocation and distribution of an eventual COVID-19 vaccine (the Federal Distribution Strategy). After briefly summarizing...more

Bricker Graydon LLP

COVID-19 Update: OMHAS issues guidance for opioid treatment programs

Bricker Graydon LLP on

Ohio Mental Health & Addiction Services (OMHAS) has issued guidance to support Ohio opioid treatment programs (OTPs) in light of the COVID-19 (coronavirus) outbreak....more

Troutman Pepper

HHS Provides Liability Immunity for Coronavirus Countermeasures

Troutman Pepper on

Makers, distributors, program planners and administering entities of coronavirus (COVID-19) countermeasures are protected from liability under a declaration issued by the Department of Health and Human Services (HHS)...more

Morgan Lewis

Potential Impact of Coronavirus (COVID-19) on the Pharmaceutical and Biotech Industries

Morgan Lewis on

The pharmaceutical and biotech industries are assessing how the coronavirus (COVID-19) pandemic may impact business operations. Presently, most countries have confirmed cases of COVID-19 and thousands of people have had...more

Morgan Lewis

Recent FDA Medical Device Developments in Response to COVID-19

Morgan Lewis on

The US Food and Drug Administration is working to facilitate emergency use authorization for coronavirus (COVID-19) medical devices, including diagnostic tests and respirators, while also working with the Federal Trade...more

Akerman LLP - Health Law Rx

Managing the Healthcare Workplace During the COVID-19 Outbreak

Healthcare providers have special concerns for their employees during the Coronavirus (COVID-19) global health emergency....more

Hogan Lovells

NHS medicine and device suppliers urged to carry out supply chain coronavirus risk assessment

Hogan Lovells on

At the end of last week, the World Health Organisation (WHO) upgraded the global risk assessment of the novel coronavirus to "very high." This comes shortly after the United Kingdom saw its first fatality as a result of...more

10 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide